Ftse Mib
33.746,66
0,00%
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
57.417,75
-1,41%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Idera Pharmaceuticals Inc (IDRA) Idera Pharmaceuticals Inc (IDRA) Notizie

IDRA

Idera Pharmaceuticals (IDRA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IDRA
DataOraFonteTitoloSimboloCompagnia
29/06/202322:31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IDRAIdera Pharmaceuticals Inc
24/06/202301:20Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IDRAIdera Pharmaceuticals Inc
17/05/202315:50Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:IDRAIdera Pharmaceuticals Inc
15/05/202323:08Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:IDRAIdera Pharmaceuticals Inc
13/04/202322:32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
10/04/202322:41Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
03/04/202312:00Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
30/03/202322:52Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
28/03/202317:29Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:IDRAIdera Pharmaceuticals Inc
14/02/202323:00Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
01/02/202322:44Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:IDRAIdera Pharmaceuticals Inc
18/01/202322:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
17/01/202314:00GlobeNewswire Inc.Idera Pharmaceuticals Announces Name Change to Aceragen, Inc. and Provides Near-Term Strategic OutlookNASDAQ:IDRAIdera Pharmaceuticals Inc
09/12/202222:50Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
14/11/202222:05GlobeNewswire Inc.Idera Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
28/09/202223:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:IDRAIdera Pharmaceuticals Inc
28/09/202222:09GlobeNewswire Inc.Idera Pharmaceuticals Acquires AceragenNASDAQ:IDRAIdera Pharmaceuticals Inc
09/08/202222:15GlobeNewswire Inc.Idera Pharmaceuticals Reports Second Quarter 2022 Financial ResultsNASDAQ:IDRAIdera Pharmaceuticals Inc
17/05/202214:04GlobeNewswire Inc.Idera Pharmaceuticals Shares Positive Results from Investigator-Sponsored Trial in Melanoma Patients at Amsterdam UMCNASDAQ:IDRAIdera Pharmaceuticals Inc
05/05/202222:15GlobeNewswire Inc.Idera Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
31/03/202222:26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:IDRAIdera Pharmaceuticals Inc
31/03/202222:15GlobeNewswire Inc.Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
14/12/202122:32GlobeNewswire Inc.Idera Pharmaceuticals Announces Tilsotolimod UpdatesNASDAQ:IDRAIdera Pharmaceuticals Inc
08/11/202122:14GlobeNewswire Inc.Idera Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
09/08/202122:15GlobeNewswire Inc.Idera Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
26/05/202112:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:IDRAIdera Pharmaceuticals Inc
19/05/202112:02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
18/05/202122:15GlobeNewswire Inc.Idera Pharmaceuticals Announces Corporate UpdatesNASDAQ:IDRAIdera Pharmaceuticals Inc
29/04/202122:10GlobeNewswire Inc.Idera Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
28/04/202122:55Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:IDRAIdera Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IDRA

La tua Cronologia

BIT
STLAM
Stellantis NV
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
TEN
Tenaris
BIT
TIT
Telecom Italia
BIT
LDO
Leonardo
BIT
SPM
Saipem
BIT
SRG
Snam
BIT
FBK
Finecobank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network